Blood types influence your health in ways that extend well beyond matching blood bags during a transfusion. Your ABO group and Rh status are linked to measurable differences in cardiovascular risk, susceptibility to certain infections, and even the composition of bacteria living in your gut. Some of these associations are modest, and none amount to a medical destiny, but the cumulative evidence across decades of research is hard to ignore.
The Basics of Blood Type and Why Transfusions Started It All
Karl Landsteiner identified the ABO blood group system in 1901, solving a lethal mystery that had plagued surgery for centuries: why some blood transfusions saved patients while others killed them within hours.1PubMed Central. Karl Landsteiner (1868-1943): A Versatile Blood Scientist The core idea is straightforward. Red blood cells carry sugar molecules on their surfaces. If your cells carry the A sugar, you are type A. If they carry the B sugar, type B. If both, AB. If neither, type O. Your immune system produces antibodies against whichever sugar your own cells lack, which is why transfusing the wrong type triggers a dangerous immune reaction.
The Rh system adds another layer, most famously the D antigen. If you have the D protein on your red cells, you are Rh-positive; without it, Rh-negative. These two systems, ABO and Rh, are what you see on your blood donor card. But the medical significance of blood type does not end once the right bag is hanging from the IV pole.
Blood Clotting and Cardiovascular Risk
One of the best-established health differences tied to blood type involves clotting. People with types A, B, or AB consistently show higher rates of both arterial and venous blood clots compared to those with type O. The link traces to a clotting protein called von Willebrand factor, or VWF. Non-O individuals have roughly 25 percent higher VWF levels than type O individuals.2PubMed. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? VWF helps platelets stick together and stabilizes another clotting factor (factor VIII), so more of it means blood that is slightly more eager to clot.
In practical terms, this translates into a modestly higher risk of deep vein thrombosis, pulmonary embolism, and certain types of stroke for non-O individuals. The effect is not enormous on its own, but it stacks with other risk factors like smoking, oral contraceptive use, or prolonged immobility. If you are type A or B and your doctor is assessing your clotting risk before surgery or a long-haul flight, your blood type is one more data point in the picture.
Cognitive Decline and Factor VIII
The same clotting pathway shows up in an unexpected place. A large study following over 30,000 adults found that people with blood type AB had a higher risk of developing cognitive impairment later in life, with roughly 82 percent greater odds compared to other blood types after adjusting for age, race, region, and sex. Higher levels of factor VIII, the clotting protein stabilized by VWF, were independently associated with cognitive decline as well.3PubMed Central. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort The thinking is that subtle vascular damage in the brain, driven partly by clotting factors, may contribute over time. AB is the rarest blood type, affecting only about 4 percent of the population, so the absolute number of people affected is small, but the finding reinforces the idea that blood type has tendrils reaching into vascular health broadly.
Malaria and the Advantage of Type O
If you have ever wondered why type O is the most common blood type worldwide, malaria may be part of the answer. The parasite Plasmodium falciparum, which causes the deadliest form of malaria, hijacks infected red blood cells and makes them stick to uninfected cells in clumps called rosettes. These rosettes clog small blood vessels and drive the severe organ damage that makes falciparum malaria so lethal.
Type O red blood cells form smaller, less stable rosettes than A, B, or AB cells, and this translates into protection against severe disease.4PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting Research has confirmed that the protective effect of group O operates specifically through reduced rosetting.5PLOS Genetics. Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria In regions of sub-Saharan Africa and Southeast Asia where malaria has been endemic for thousands of years, the prevalence of type O is notably higher than in malaria-free regions, suggesting that natural selection has favored it in those populations.
This is a compelling example of how an infectious disease can shape the genetics of an entire population over centuries. Type O confers a survival edge in malaria zones, but as we will see, it comes with trade-offs elsewhere.
The Duffy System and a Different Kind of Malaria Resistance
ABO is just one of over 40 recognized blood group systems, and at least one other has an equally dramatic relationship with malaria. The Duffy blood group system involves a protein on red blood cells that the parasite Plasmodium vivax uses as a doorway to enter cells. People who lack both Duffy antigens, a phenotype common in West and Central African populations, are resistant to vivax malaria because the parasite simply cannot get in.6PubMed. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy This finding was long considered ironclad, and it remains largely true, though researchers have documented some vivax infections in Duffy-negative individuals in Madagascar, suggesting the parasite may be slowly evolving workarounds.7PubMed Central. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people
The Duffy story underscores a broader point: blood group systems are not just labels for transfusion compatibility. They are molecular structures on cell surfaces, and pathogens have been exploiting or colliding with them for as long as humans and microbes have coexisted.
Stomach Ulcers, Norovirus, and the Gut
Your blood type antigens are not confined to your red blood cells. About 80 percent of people are “secretors,” meaning they also express blood group sugars on the surfaces of cells lining the digestive and respiratory tracts, and in saliva and other body fluids. This turns the gut lining into a landscape the microbial world can read.
Helicobacter pylori, the bacterium responsible for most stomach ulcers and a major risk factor for gastric cancer, carries a protein called BabA that binds preferentially to the H antigen found at high levels in the stomach cells of type O secretors. This helps explain the long-observed association between type O blood and higher rates of peptic ulcers.8PubMed Central. ABO, Lewis blood group systems and secretory status with H. pylori infection in yemeni dyspeptic patients: a cross-sectional study So while type O offers protection against malaria and blood clots, it appears to leave the stomach more vulnerable to H. pylori colonization.
Norovirus and rotavirus play a similar game. These viruses latch onto blood group sugars on the intestinal lining as part of their entry strategy. Secretors, who display those sugars in the gut, are susceptible to these infections, while non-secretors, who do not, are largely resistant.9The Pediatric Infectious Disease Journal. Secretors of HBGA and Susceptibility to Norovirus and Rotavirus Diarrhea Your secretor status, which is determined by a different gene than ABO, effectively acts as a gatekeeper that either lets certain gut pathogens grab hold or shuts them out.
Blood Type and the Gut Microbiome
Those same sugars on the gut lining also feed the bacteria already living there. Research has found that people who carry the B antigen, whether type B or AB, tend to have a different composition of intestinal bacteria, including higher diversity in certain bacterial groups, compared to non-B individuals.10PubMed Central. Association between the ABO blood group and the human intestinal microbiota composition More recently, scientists showed that a common gut bacterium called Ruminococcus gnavus carries an enzyme that specifically targets and breaks down the A antigen on gut mucin. By doing so, the bacterium gains access to sugars buried deeper in the mucus layer, giving it a nutritional niche that depends on the host’s blood type.11PLOS Biology. The human gut symbiont Ruminococcus gnavus shows specificity to blood group A antigen during mucin glycan foraging
The implications of this are still being worked out, but the principle is clear: your blood type antigens shape the environment in your gut, and the microbial community responds accordingly. Whether those microbiome differences meaningfully affect digestion, immune function, or disease risk is an active area of investigation.
Pancreatic Cancer Risk
Among the more striking associations between blood type and disease is the link to pancreatic cancer. Two large studies found that non-O blood types carry a significantly higher risk. In a prospective study following health professionals over decades, people with types A, B, and AB had adjusted hazard ratios of 1.32, 1.72, and 1.51 for pancreatic cancer, respectively, compared to type O. The researchers estimated that about 17 percent of pancreatic cancer cases in their study population were attributable to having a non-O blood type.12PubMed Central. ABO Blood Group and the Risk of Pancreatic Cancer A separate case-control study confirmed the association, finding roughly 37 percent higher odds of pancreatic cancer in non-O individuals, with an additional independent risk from certain H. pylori infections.13JNCI: Journal of the National Cancer Institute. ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study
Pancreatic cancer is relatively rare, so even a 30 to 70 percent relative increase in risk still translates to a small absolute risk for any individual. But because pancreatic cancer is so deadly and so difficult to detect early, any identifiable risk factor gets attention. The mechanism is not fully understood, though the VWF and clotting pathway as well as chronic inflammation are candidates under investigation.
Diabetes and Metabolic Risk
Blood type also appears to nudge risk for type 2 diabetes, though the picture here is a bit muddled. A large French cohort study found that people with type A or B had modestly higher diabetes risk compared to type O, with the greatest increase seen in those with B-positive blood, who had about 35 percent higher risk than the O-negative reference group.14PubMed. ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study Another study from a different population similarly pointed to type B as carrying the highest diabetes incidence, with type O showing the lowest.15PubMed. Association of ABO and Rh blood groups with type 2 diabetes mellitus
Interestingly, a genetic study examining the ABO region on chromosome 9 found that variants there influence levels of soluble E-selectin, an inflammatory molecule involved in how blood vessel walls interact with immune cells. When the researchers adjusted for E-selectin and other inflammatory markers, the relationship between ABO genotype and diabetes risk shifted, suggesting that inflammation and vascular biology may partly explain the link.16Human Molecular Genetics. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes The effect sizes are small enough that blood type alone would never be a useful screening tool for diabetes, but it adds to the pattern: ABO is subtly intertwined with metabolic and vascular processes.
Pregnancy and Rh Incompatibility
If blood type has one undeniable, high-stakes clinical consequence outside of transfusion, it is Rh incompatibility during pregnancy. When an Rh-negative mother carries an Rh-positive baby, small amounts of the baby’s blood can cross the placenta and trigger the mother’s immune system to produce anti-D antibodies. In a first pregnancy this usually causes no harm, but in subsequent pregnancies with another Rh-positive baby, those antibodies can cross the placenta and attack the baby’s red blood cells, causing hemolytic disease of the newborn.
The D antigen is powerfully immunogenic. After exposure to D-positive red blood cells, roughly 80 percent of D-negative recipients develop anti-D antibodies, and the D antigen is involved in about 95 percent of cases of hemolytic disease of the newborn.17PubMed Central. Fetal–maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis Modern medicine has largely tamed this problem with Rh immunoglobulin (RhoGAM) injections given to Rh-negative mothers during and after pregnancy, preventing the immune response before it starts. But in parts of the world where this treatment is not reliably available, Rh disease remains a serious cause of newborn illness and death.
COVID-19 and Blood Type
Early in the COVID-19 pandemic, reports emerged suggesting that blood type O might offer some protection against SARS-CoV-2 infection or severe disease, while type A was associated with higher risk. A review conducted on behalf of an international working group found that the evidence ranged from small observational studies to genome-wide association analyses and country-level meta-regressions.18PubMed Central. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group The pattern across these studies was suggestive but far from definitive, and the effect sizes were small. Given the overwhelming importance of vaccination status, age, and underlying conditions in determining COVID outcomes, blood type was never going to be a clinically useful predictor. Still, the research reinforced the recurring theme of type O being slightly less vulnerable to certain infectious threats, possibly because anti-A and anti-B antibodies in O-type blood interfere with viral particles that have picked up host cell sugars.
The Blood Type Diet Myth
With all these genuine health associations, it is worth addressing one that is not real. The “blood type diet,” popularized in the late 1990s, claims that people should eat differently based on their ABO type, with type O supposedly thriving on a high-protein diet, type A on a vegetarian diet, and so on. A systematic review searching for any evidence to support these claims came up empty. No controlled studies had validated the idea that matching your diet to your blood type produces better health outcomes than any other reasonable diet.19PubMed. Blood type diets lack supporting evidence: a systematic review
People who follow the type A diet may well feel better, but that is because the type A diet happens to be a plant-rich whole-foods diet, which benefits basically everyone. The improvement has nothing to do with blood type. The real health links between blood type and disease operate through molecular mechanisms on cell surfaces and in the bloodstream, not through how you digest a steak.
Why Evolution Kept Multiple Blood Types Around
Given all these disease associations, you might wonder why natural selection has not simply driven everyone toward whichever blood type is “best.” The answer is that no single type is best overall. Type O offers advantages against malaria and blood clots but disadvantages with ulcers. Non-O types may fare better with certain gut pathogens but worse with clotting. This kind of trade-off, where each variant has context-dependent advantages, is what keeps genetic diversity alive in a population.
Genetic evidence suggests that functional A and B alleles were both present in the common ancestors of primates, and that ABO genes have evolved under persistent selective pressure to maintain some degree of variation in their sugar-modifying activity.20Scientific Reports. An integrative evolution theory of histo-blood group ABO and related genes In evolutionary terms, the ABO polymorphism is ancient, and the fact that it persists across so many primate species suggests it has been actively maintained rather than drifting randomly.
Engineering Universal Blood
One of the more exciting frontiers in blood science is the effort to create truly universal donor blood by enzymatically stripping the A and B sugars off red blood cells, converting them to type O. Since the difference between blood types is just one or two sugar molecules, the concept is elegant: find the right enzyme, clip off the sugar, and any donated blood becomes compatible with any recipient.
Researchers discovered that gut bacteria, which routinely encounter blood group sugars on the mucus lining of the intestine, are a rich source of the enzymes needed for this conversion. A pair of enzymes from the gut bacterium Flavonifractor plautii was shown to efficiently convert type A red blood cells to type O at very low enzyme concentrations in whole blood.21Nature Microbiology. An enzymatic pathway in the human gut microbiome that converts A to universal O type blood More recently, a team working with enzymes from Akkermansia muciniphila found combinations that could remove not only the standard A and B antigens but also several of their extended carbohydrate variants, improving compatibility with type O plasma beyond what earlier approaches achieved.22Nature Microbiology. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood
This technology is not yet in clinical use, and hurdles remain around cost, scale, and ensuring complete antigen removal before the blood is transfused. But if it works, it could simplify blood supply logistics enormously, reducing waste from expired type-specific units and easing shortages during emergencies. The fact that the tools to solve this problem were hiding in the human gut microbiome is a satisfying twist: the same microbial ecosystem shaped by blood type antigens may eventually help us transcend the constraints those antigens impose.